New Hydrogen Nanoparticle Therapy Kills Melanoma Cancer Cells

Authors
Journal
International Journal of Biological Macromolecules
Year
DOI
10.1016/j.ijbiomac.2026.150278
Study Type
Cell Culture
Outcome
Positive
Peer Reviewed
Yes
Country
Iran
Health Condition
Melanoma
Body System
Integumentary

TL;DR

A light-activated nanomaterial that generates hydrogen and reactive oxygen species enhanced cancer cell killing and improved anticancer therapy effectiveness.

Key Finding

An engineered nanoparticle combining platinum-decorated carbon nitride with iron and chitosan killed melanoma cells nearly 9 times more effectively under visible-light exposure (IC₅₀ of 33 μg/mL) compared to dark conditions (IC₅₀ of 290 μg/mL).

Summary

Researchers created a specially engineered nanoparticle (a tiny particle made from carbon, nitrogen, platinum, and iron) designed to kill cancer cells when exposed to visible light. The nanoparticle works through multiple mechanisms: it generates reactive oxygen species (unstable molecules that damage cells), depletes glutathione (a protective molecule cancer cells use to defend themselves), and produces hydrogen gas. In laboratory tests using melanoma cells, the nanoparticle was significantly more effective at killing cancer cells when exposed to light compared to darkness.

Practical Takeaway

This is early-stage laboratory research in cancer cells, not a study of hydrogen water as a supplement. The work explores how hydrogen gas produced by engineered nanoparticles might contribute to cancer cell death when combined with light exposure and other mechanisms. This is fundamentally different from drinking hydrogen-enriched water, and no conclusions about hydrogen water's health effects can be drawn from this study.

Abstract (excerpt)

Graphitic carbon nitride (g-C3N4) has attracted considerable attention as a multifunctional platform for cancer therapy, including photodynamic therapy (PDT) and hydrogen (H2)-based therapeutic strategies, owing to its intrinsic photocatalytic activity. Nevertheless, its clinical translation…

Read the full abstract via DOI